Annalise Enterprise CTB
General Information
Product name
Annalise Enterprise CTB
Company
Subspeciality
Neuro
Modality
CT
Disease targeted
130 findings present in the emergent, urgent, and non-urgent care settings including: Intracranial haemorrhage, haematomas (acute subdural/extradural), fractures, pneumocephalus, infarct, mass effect & midline shift, obstructive hydrocephalus, Intraaxial mass, transependymal oedema, colloid cyst, vasogenic oedema, and many others.
Main task
Not specified
Technical Specifications
Population
All non-contrast head CT studies for patients over 18 years of age
Patient population age
Not specified
Input
Non-contrast CT
Input format
DICOM
Output
Indication of presence of finding, segmentation overlay, confidence and threshold score/bar
Output format
Customizable AI Viewer. DICOM SC. Worklist – HL7 or API based output for worklist triage (prioritisation)
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment
Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Trigger for analysis
Automatically, Right after the image acquisition
Processing time
1 - 10 minutes
Regulatory Information
CE Certification
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
FDA Certification
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
07-2022
AI Platforms
Blackford Analysis, Newton's Tree, Nuance, Sectra
Resellers
Not specified
Countries present
40+
Paying clinical customers
300+
Research/test users
10+
Pricing Information
Pricing model
Subscription
Based on
Number of analyses
Source: vendor | First published: Jun 9, 2024 | Last updated: Jul 21, 2025